FindMyKOL

Poorna Karuparthi, MD

Basic profile

Harry S. Truman Memorial Veterans' Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionColumbia, MO · MidwestSpecialtyInterventional CardiologyFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Poorna Karuparthi is a Cardiology physician affiliated with Harry S. Truman Memorial Veterans' Hospital. OpenAlex indexes 44 publications with 839 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
44publications

Publications indexed by OpenAlex. Counts exclude supporting files.

839citations

Citations across these publications.

13h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
18companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Medtronic, Inc.
    Program year202520 payments
    $1,887
  • AstraZeneca Pharmaceuticals LP
    Program year20251 payment
    $106
  • Boston Scientific Corporation
    Program year20251 payment
    $92
All 36 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    69.1%
    Beta blocker20.3%
    Metoprolol Tartrate57%Metoprolol Succinate28%Carvedilol16%
    Part D<11 patients
    Statin13.2%
    Atorvastatin Calcium58%Rosuvastatin Calcium42%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    26.8%
    Factor Xa inhibitor18.2%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor8.5%
    Brilinta55%Clopidogrel45%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4.1%
    Proton pump inhibitor4.1%
    Pantoprazole Sodium100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”